Firefly Neuroscience (AIFF) Cash from Investing Activities Growth (3y) (2013 - 2026)
Powered by 
Analysis
Firefly Neuroscience (AIFF) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | -11.04% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 53.94% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -37.18% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -3.40% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | -36.38% |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | - |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 34.87% |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -27.28% |
| Dec 31, 2025 | 57.60% |
| Sep 30, 2025 | 24.90% |
| Jun 30, 2025 | -397.53% |
| Mar 31, 2025 | 15.91% |
| Sep 30, 2024 | -128.63% |
| Jun 30, 2024 | 48.25% |
| Mar 31, 2024 | -205.11% |
| Dec 31, 2023 | -302.79% |
| Sep 30, 2023 | -165.80% |
| Dec 31, 2022 | -563.15% |
| Sep 30, 2022 | -429.45% |
| Jun 30, 2022 | -47.80% |
| Dec 31, 2021 | -1,526.10% |
| Sep 30, 2021 | -205.84% |
| Jun 30, 2021 | -2,372.35% |
| Mar 31, 2021 | -64.61% |
| Dec 31, 2020 | -338.62% |
| Sep 30, 2020 | -311.40% |
| Dec 31, 2019 | -5.68% |